157 related articles for article (PubMed ID: 26423034)
1. Discovery of Novel Selective ERα/ERβ Ligands by Multi-pharmacophore Modeling and Virtual Screening.
Huang W; Wei W; Yang Y; Zhang T; Shen Z
Chem Pharm Bull (Tokyo); 2015; 63(10):780-91. PubMed ID: 26423034
[TBL] [Abstract][Full Text] [Related]
2. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
4. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
Shen J; Li W; Liu G; Tang Y; Jiang H
J Phys Chem B; 2009 Jul; 113(30):10436-44. PubMed ID: 19583238
[TBL] [Abstract][Full Text] [Related]
5. Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.
Hsieh RW; Rajan SS; Sharma SK; Guo Y; DeSombre ER; Mrksich M; Greene GL
J Biol Chem; 2006 Jun; 281(26):17909-19. PubMed ID: 16648639
[TBL] [Abstract][Full Text] [Related]
6. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
[TBL] [Abstract][Full Text] [Related]
7. A Computational-Based Approach to Identify Estrogen Receptor
Coriano CG; Liu F; Sievers CK; Liang M; Wang Y; Lim Y; Yu M; Xu W
Mol Pharmacol; 2018 Mar; 93(3):197-207. PubMed ID: 29295894
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol.
Yoo J; Dence CS; Sharp TL; Katzenellenbogen JA; Welch MJ
J Med Chem; 2005 Oct; 48(20):6366-78. PubMed ID: 16190762
[TBL] [Abstract][Full Text] [Related]
9. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
Wolohan P; Reichert DE
J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy.
Yu E; Xu Y; Shi Y; Yu Q; Liu J; Xu L
J Mol Model; 2019 Aug; 25(9):278. PubMed ID: 31463793
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
[TBL] [Abstract][Full Text] [Related]
12. Computational Insights into Ligand Selectivity of Estrogen Receptors from Pharmacophore Modeling.
Fang J; Shen J; Cheng F; Xu Z; Liu G; Tang Y
Mol Inform; 2011 Jun; 30(6-7):539-49. PubMed ID: 27467155
[TBL] [Abstract][Full Text] [Related]
13. Target specific virtual screening: optimization of an estrogen receptor screening platform.
Knox AJ; Meegan MJ; Sobolev V; Frost D; Zisterer DM; Williams DC; Lloyd DG
J Med Chem; 2007 Nov; 50(22):5301-10. PubMed ID: 17918820
[TBL] [Abstract][Full Text] [Related]
14. In silico prediction of estrogen receptor subtype binding affinity and selectivity using statistical methods and molecular docking with 2-arylnaphthalenes and 2-arylquinolines.
Wang Z; Li Y; Ai C; Wang Y
Int J Mol Sci; 2010 Sep; 11(9):3434-58. PubMed ID: 20957105
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
[TBL] [Abstract][Full Text] [Related]
16. Discovery of natural estrogen receptor modulators with structure-based virtual screening.
Cao X; Jiang J; Zhang S; Zhu L; Zou J; Diao Y; Xiao W; Shan L; Sun H; Zhang W; Huang J; Li H
Bioorg Med Chem Lett; 2013 Jun; 23(11):3329-33. PubMed ID: 23608764
[TBL] [Abstract][Full Text] [Related]
17. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
Ozers MS; Ervin KM; Steffen CL; Fronczak JA; Lebakken CS; Carnahan KA; Lowery RG; Burke TJ
Mol Endocrinol; 2005 Jan; 19(1):25-34. PubMed ID: 15375189
[TBL] [Abstract][Full Text] [Related]
18. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of fragment-like estrogen receptor tetrahydroisoquinoline ligands from a scaffold-detection approach.
Möcklinghoff S; van Otterlo WA; Rose R; Fuchs S; Zimmermann TJ; Dominguez Seoane M; Waldmann H; Ottmann C; Brunsveld L
J Med Chem; 2011 Apr; 54(7):2005-11. PubMed ID: 21381753
[TBL] [Abstract][Full Text] [Related]
20. A screening cascade to identify ERβ ligands.
Filgueira CS; Benod C; Lou X; Gunamalai PS; Villagomez RA; Strom A; Gustafsson JÅ; Berkenstam AL; Webb P
Nucl Recept Signal; 2014; 12():e003. PubMed ID: 25422593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
